Dysautonomia Clinical Trials

10 recruiting

Dysautonomia Trials at a Glance

10 actively recruiting trials for dysautonomia are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Bethesda, Delafield, and Milwaukee. Lead sponsors running dysautonomia studies include Centre Hospitalier Universitaire de Saint Etienne, Medical College of Wisconsin, and Brain Inflammation Collaborative.

Browse dysautonomia trials by phase

Treatments under study

About Dysautonomia Clinical Trials

Looking for clinical trials for Dysautonomia? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Dysautonomia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Dysautonomia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Not Applicable

Blood Pressure Effects on Cognition and Brain Blood Flow in PD

DysautonomiaParkinson DiseaseOrthostatic Hypotension
University of California, San Diego60 enrolled1 locationNCT05400174
Recruiting

Data Collection of Standard Care of Patients in the EMG Section

NeuropathyDysautonomiaMuscle Disorders
National Institute of Neurological Disorders and Stroke (NINDS)200 enrolled1 locationNCT05041387
Recruiting
Not Applicable

Dysautonomia in Children With Type 1 Diabetes

Healthy VolunteerDysautonomia in Children With Type 1 Diabetes
Centre Hospitalier Universitaire de Saint Etienne100 enrolled1 locationNCT07455994
Recruiting
Phase 2

Personalized Brain Stimulation to Treat Chronic Concussive Symptoms

DepressionAnxietyDysautonomia+8 more
University of California, Los Angeles75 enrolled1 locationNCT06073886
Recruiting
Not Applicable

Autonomic Reactivity and Personalized Neurostimulation

DysautonomiaFunctional DyspepsiaFunctional Gastrointestinal Disorders (FGIDs)+1 more
Medical College of Wisconsin120 enrolled1 locationNCT06863207
Recruiting

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Post-Acute COVID-19 SyndromeME/CFSRheumatic Arthritis+14 more
Brain Inflammation Collaborative10,000 enrolled1 locationNCT04806620
Recruiting

The Natural History of Familial Dysautonomia

Familial Dysautonomia (Riley-Day Syndrome)Hereditary Sensory and Autonomic NeuropathiesHereditary Sensory and Autonomic Neuropathy 3
NYU Langone Health400 enrolled2 locationsNCT03920774
Recruiting

Determining the prevalence of Postural Orthostatic Tachycardia Syndrome (POTS) in patients attending the emergency department (ED) with orthostatic symptoms.

Dysautonomia
The University of Adelaide500 enrolled1 locationACTRN12625000531415
Recruiting

Are the postural orthostatic tachycardia syndrome diagnostic criteria limiting? Defining and comparing patient reported outcomes of an Australian cohort with postural symptoms without tachycardia

Dysautonomia
University of Adelaide500 enrolled1 locationACTRN12625000058471
Recruiting
Not Applicable

Effects of Osteopathic Technique on Autonomic Nervous System Activity

HealthyDysautonomia
SomaticMed109 enrolled1 locationNCT06554834